GeoVax Labs, Inc. (GOVX) financial statements (2022 and earlier)

Company profile

Business Address 1900 LAKE PARK DRIVE
SMYRNA, GA 30080
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments11,4249,8842832603134541,060
Cash and cash equivalents11,4249,8842832603134541,060
Other undisclosed current assets20535116436013590177
Total current assets:11,62910,2354476204485441,237
Noncurrent Assets
Property, plant and equipment1571481111315584
Other noncurrent assets     1111
Other undisclosed noncurrent assets1111111111  
Total noncurrent assets:1681592222426695
TOTAL ASSETS:11,79710,3944696424906101,332
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities5,4356272,0041,364811370105
Accounts payable2,0582681531267876101
Accrued liabilities3,3783591,8511,2397342944
Debt 18313260   
Due to related parties      22
Total current liabilities:5,4358102,0161,625811370127
Noncurrent Liabilities
Long-term debt and lease obligation 152740   
Long-term debt, excluding current maturities 152740   
Other undisclosed noncurrent liabilities2,000      
Total noncurrent liabilities:2,000152740   
Total liabilities:7,4358252,0431,664811370127
Stockholders' equity
Stockholders' equity attributable to parent, including:4,3629,569(1,575)(1,022)(321)2401,205
Preferred stock 761,932    
Common stock6402191075532
Additional paid in capital68,73155,29539,34037,26435,59034,91532,588
Accumulated deficit(64,376)(45,806)(42,848)(40,477)(37,917)(35,747)(32,475)
Other undisclosed stockholders' equity attributable to parent   1,9711,8991,0171,060
Total stockholders' equity:4,3629,569(1,575)(1,022)(321)2401,205
TOTAL LIABILITIES AND EQUITY:11,79710,3944696424906101,332

Income statement (P&L) ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Revenues3861,8241,1769631,075829428
Revenue, net1,075829428
Gross profit:3861,8241,1769631,075829428
Operating expenses(19,131)(4,640)(3,548)(3,526)(3,250)(4,102)(3,123)
Operating loss:(18,746)(2,817)(2,372)(2,563)(2,174)(3,273)(2,695)
Nonoperating income (expense)176(141)23425
Investment income, nonoperating5265425
Interest and debt expense172(144)(4)(3)   
Net loss:(18,398)(3,102)(2,375)(2,563)(2,170)(3,272)(2,689)
Other undisclosed net income (loss) attributable to parent(172)14443   
Net loss available to common stockholders, diluted:(18,570)(2,958)(2,371)(2,560)(2,170)(3,272)(2,689)

Comprehensive Income ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Net loss:(18,398)(3,102)(2,375)(2,563)(2,170)(3,272)(2,689)
Comprehensive loss, net of tax, attributable to parent:(18,398)(3,102)(2,375)(2,563)(2,170)(3,272)(2,689)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: